Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.

Let’s show the aligned purpose of caring for the well-being of patients!

American Voters Must Add the Environment to Their Ballot-Box Priorities – Sustainability is No Laughing Matter

The imperative for immediate and transformative change echoes across diverse industry sectors